AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates. The company’s first-quarter earnings were roughly in line with Wall Street expectations. AbbVie (ticker: ABBV) … Read more